These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25554417)

  • 1. MiR-10a and miR-181c regulate collagen type I generation in hypertrophic scars by targeting PAI-1 and uPA.
    Li C; Zhu HY; Bai WD; Su LL; Liu JQ; Cai WX; Zhao B; Gao JX; Han SC; Li J; Hu DH
    FEBS Lett; 2015 Jan; 589(3):380-9. PubMed ID: 25554417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
    J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lapachol suppresses cell proliferation and secretion of interleukin-6 and plasminogen activator inhibitor-1 of fibroblasts derived from hypertrophic scars.
    Matsui T; Ito C; Oda M; Itoigawa M; Yokoo K; Okada T; Furukawa H
    J Pharm Pharmacol; 2011 Jul; 63(7):960-6. PubMed ID: 21635262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocytes and head and neck squamous cell carcinoma cells regulate urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in fibroblasts.
    Hakelius M; Koskela A; Ivarsson M; Grenman R; Rubin K; Gerdin B; Nowinski D
    Anticancer Res; 2013 Aug; 33(8):3113-8. PubMed ID: 23898067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress of tissue injury in appendicitis involves the serine proteases uPA and PAI-1.
    Solberg A; Holmdahl L; Falk P; Willén R; Palmgren I; Ivarsson ML
    Scand J Gastroenterol; 2009; 44(5):579-84. PubMed ID: 19153874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-192 regulates hypertrophic scar fibrosis by targeting SIP1.
    Li Y; Zhang J; Zhang W; Liu Y; Li Y; Wang K; Zhang Y; Yang C; Li X; Shi J; Su L; Hu D
    J Mol Histol; 2017 Dec; 48(5-6):357-366. PubMed ID: 28884252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression of fibrinolytic factors urokinase plasminogen activator and plasminogen activator inhibitor-1 in rabbit temporo-mandibular joint cartilage with disc displacement.
    Zhan J; Gu ZY; Wu LQ; Zhang YK; Hu JA
    Chin Med J (Engl); 2005 Jun; 118(12):1000-6. PubMed ID: 15978208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors.
    Braza-Boïls A; Marí-Alexandre J; Gilabert J; Sánchez-Izquierdo D; España F; Estellés A; Gilabert-Estellés J
    Hum Reprod; 2014 May; 29(5):978-88. PubMed ID: 24608518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures.
    Tuan TL; Wu H; Huang EY; Chong SS; Laug W; Messadi D; Kelly P; Le A
    Am J Pathol; 2003 May; 162(5):1579-89. PubMed ID: 12707042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
    Feng Q; Liu Y; Liu K; Byrne S; Liu G; Wang X; Li Z; Ockleford CD
    Placenta; 2000; 21(2-3):184-93. PubMed ID: 10736241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism of urokinase-type plasminogen activator is interacting with plasminogen activator inhibitor-1 to raise risk of cervical neoplasia.
    Tee YT; Wang PH; Tsai HT; Lin LY; Lin HT; Yang SF; Hsieh YH; Ying TH
    J Surg Oncol; 2012 Aug; 106(2):204-8. PubMed ID: 22354580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the role of Hsa-miR-31-5p in hypertrophic scar formation and the mechanism.
    Wang X; Zhang Y; Jiang BH; Zhang Q; Zhou RP; Zhang L; Wang C
    Exp Cell Res; 2017 Dec; 361(2):201-209. PubMed ID: 29056521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of N-(4-hydroxyphenyl) retinamide on urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in prostate adenocarcinoma cell lines.
    Tanabe T
    Hiroshima J Med Sci; 2000 Mar; 49(1):67-72. PubMed ID: 10824459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
    Skeldal S; Larsen JV; Pedersen KE; Petersen HH; Egelund R; Christensen A; Jensen JK; Gliemann J; Andreasen PA
    FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.